Aurinia Pharmaceuticals Inc. (AUPH)
USD 8.21
(0.12%)
USD 8.21
(0.12%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 161.36 Million USD | 25.71% |
| 2022 | 128.36 Million USD | 188.37% |
| 2021 | 44.51 Million USD | 21398.56% |
| 2020 | -209 Thousand USD | 99.6% |
| 2019 | -52.54 Million USD | -28.42% |
| 2018 | -40.91 Million USD | -9865.87% |
| 2017 | 419 Thousand USD | 147.93% |
| 2016 | 169 Thousand USD | -24.22% |
| 2015 | 223 Thousand USD | -7.47% |
| 2014 | 241 Thousand USD | -74.57% |
| 2013 | 947.62 Thousand USD | -84.49% |
| 2012 | 6.11 Million USD | 723.21% |
| 2011 | 742.41 Thousand USD | -77.97% |
| 2010 | 3.36 Million USD | -3.07% |
| 2009 | 3.47 Million USD | 97.32% |
| 2008 | 1.76 Million USD | 37.16% |
| 2007 | 1.28 Million USD | -56.09% |
| 2006 | 2.92 Million USD | 148.37% |
| 2005 | 1.17 Million USD | -7.51% |
| 2004 | 1.27 Million USD | -83.38% |
| 2003 | 7.66 Million USD | -31.78% |
| 2002 | 11.23 Million USD | 162.89% |
| 2001 | 4.27 Million USD | 1823.39% |
| 2000 | 222.11 Thousand USD | -67.29% |
| 1999 | 679.09 Thousand USD | 160.77% |
| 1998 | 260.41 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 42.55 Million USD | 7.18% |
| 2024 Q2 | 48.28 Million USD | 13.47% |
| 2023 Q2 | 39.93 Million USD | 17.49% |
| 2023 Q4 | 39.7 Million USD | -16.85% |
| 2023 Q3 | 47.74 Million USD | 19.57% |
| 2023 Q1 | 33.98 Million USD | 25.54% |
| 2023 FY | 161.36 Million USD | 25.71% |
| 2022 Q3 | 53.33 Million USD | 100.56% |
| 2022 Q2 | 26.59 Million USD | 24.44% |
| 2022 Q1 | 21.36 Million USD | -6.78% |
| 2022 FY | 128.36 Million USD | 188.37% |
| 2022 Q4 | 27.07 Million USD | -49.24% |
| 2021 Q1 | 866 Thousand USD | -97.65% |
| 2021 Q2 | 6.31 Million USD | 628.87% |
| 2021 FY | 44.51 Million USD | 21398.56% |
| 2021 Q4 | 22.92 Million USD | 59.04% |
| 2021 Q3 | 14.41 Million USD | 128.34% |
| 2020 Q2 | -11.04 Million USD | 19.98% |
| 2020 Q3 | -4.77 Million USD | 56.81% |
| 2020 Q4 | 36.85 Million USD | 872.52% |
| 2020 Q1 | -13.8 Million USD | -4.09% |
| 2020 FY | -209 Thousand USD | 99.6% |
| 2019 Q3 | -17.56 Million USD | -57.88% |
| 2019 Q4 | -13.26 Million USD | 24.47% |
| 2019 Q2 | -11.12 Million USD | -4.92% |
| 2019 FY | -52.54 Million USD | -28.42% |
| 2019 Q1 | -10.6 Million USD | 1.93% |
| 2018 Q3 | -10.77 Million USD | -2.88% |
| 2018 Q1 | -8.85 Million USD | -2.27% |
| 2018 FY | -40.91 Million USD | -9865.87% |
| 2018 Q4 | -10.81 Million USD | -0.31% |
| 2018 Q2 | -10.47 Million USD | -18.27% |
| 2017 Q3 | -10.77 Million USD | -59.01% |
| 2017 FY | 419 Thousand USD | 147.93% |
| 2017 Q4 | -8.66 Million USD | 19.65% |
| 2017 Q1 | 30 Thousand USD | 3.45% |
| 2017 Q2 | -6.77 Million USD | -22693.33% |
| 2016 Q2 | 54 Thousand USD | -3.57% |
| 2016 Q4 | 29 Thousand USD | -3.33% |
| 2016 FY | 169 Thousand USD | -24.22% |
| 2016 Q3 | 30 Thousand USD | -44.44% |
| 2016 Q1 | 56 Thousand USD | 1.82% |
| 2015 Q3 | 56 Thousand USD | 1.82% |
| 2015 FY | 223 Thousand USD | -7.47% |
| 2015 Q2 | 55 Thousand USD | -3.51% |
| 2015 Q1 | 57 Thousand USD | -5.0% |
| 2015 Q4 | 55 Thousand USD | -1.79% |
| 2014 Q4 | 60 Thousand USD | -1.64% |
| 2014 Q3 | 61 Thousand USD | 0.0% |
| 2014 Q2 | 61 Thousand USD | 3.39% |
| 2014 Q1 | 59 Thousand USD | -91.47% |
| 2014 FY | 241 Thousand USD | -74.57% |
| 2013 Q3 | -439.66 Thousand USD | -22.36% |
| 2013 Q1 | 86.49 Thousand USD | 8.67% |
| 2013 Q4 | 691.7 Thousand USD | 257.33% |
| 2013 FY | 947.62 Thousand USD | -84.49% |
| 2013 Q2 | -359.31 Thousand USD | -515.44% |
| 2012 FY | 6.11 Million USD | 723.21% |
| 2012 Q4 | 79.59 Thousand USD | 1.74% |
| 2012 Q3 | 78.23 Thousand USD | 0.72% |
| 2012 Q2 | 77.67 Thousand USD | -98.66% |
| 2012 Q1 | 5.79 Million USD | 5346.41% |
| 2011 Q1 | -17.49 Thousand USD | -106.06% |
| 2011 Q4 | 106.38 Thousand USD | -79.67% |
| 2011 Q3 | 523.27 Thousand USD | 281.05% |
| 2011 FY | 742.41 Thousand USD | -77.97% |
| 2011 Q2 | 137.32 Thousand USD | 885.06% |
| 2010 Q1 | 1.42 Million USD | -12.17% |
| 2010 FY | 3.36 Million USD | -3.07% |
| 2010 Q4 | 288.43 Thousand USD | 13.16% |
| 2010 Q3 | 254.89 Thousand USD | -81.91% |
| 2010 Q2 | 1.4 Million USD | -0.82% |
| 2009 Q1 | 647.02 Thousand USD | 159.5% |
| 2009 Q4 | 1.61 Million USD | 76.77% |
| 2009 FY | 3.47 Million USD | 97.32% |
| 2009 Q2 | 381.58 Thousand USD | -41.02% |
| 2009 Q3 | 914.96 Thousand USD | 139.78% |
| 2008 FY | 1.76 Million USD | 37.16% |
| 2008 Q4 | 249.33 Thousand USD | -72.19% |
| 2008 Q3 | 896.46 Thousand USD | 173.18% |
| 2008 Q2 | 328.15 Thousand USD | 6.22% |
| 2008 Q1 | 308.94 Thousand USD | 25.6% |
| 2007 Q1 | 605.92 Thousand USD | 28.23% |
| 2007 Q4 | 245.98 Thousand USD | -7.5% |
| 2007 Q3 | 265.91 Thousand USD | 0.02% |
| 2007 Q2 | 265.85 Thousand USD | -56.12% |
| 2007 FY | 1.28 Million USD | -56.09% |
| 2006 Q3 | 360.91 Thousand USD | -55.37% |
| 2006 Q2 | 808.65 Thousand USD | -40.93% |
| 2006 Q1 | 1.36 Million USD | 221.08% |
| 2006 Q4 | 472.55 Thousand USD | 30.93% |
| 2006 FY | 2.92 Million USD | 148.37% |
| 2005 Q3 | 1.76 Million USD | 764.01% |
| 2005 FY | 1.17 Million USD | -7.51% |
| 2005 Q2 | 204.07 Thousand USD | -35.71% |
| 2005 Q1 | 317.43 Thousand USD | 24.25% |
| 2005 Q4 | -1.13 Million USD | -164.12% |
| 2004 Q3 | 262.45 Thousand USD | 2.91% |
| 2004 FY | 1.27 Million USD | -83.38% |
| 2004 Q1 | 467.5 Thousand USD | -24.06% |
| 2004 Q4 | 255.47 Thousand USD | -2.66% |
| 2004 Q2 | 255.03 Thousand USD | -45.45% |
| 2003 Q3 | 306.91 Thousand USD | -95.3% |
| 2003 Q1 | 215.97 Thousand USD | 18.16% |
| 2003 FY | 7.66 Million USD | -31.78% |
| 2003 Q4 | 615.63 Thousand USD | 100.59% |
| 2003 Q2 | 6.52 Million USD | 2923.27% |
| 2002 Q1 | 2.06 Million USD | 0.0% |
| 2002 FY | 11.23 Million USD | 162.89% |
| 2002 Q4 | 182.78 Thousand USD | -95.42% |
| 2002 Q3 | 3.99 Million USD | -23.44% |
| 2002 Q2 | 5.21 Million USD | 152.34% |
| 2001 Q2 | 145.68 Thousand USD | -8.25% |
| 2001 Q1 | 158.79 Thousand USD | 94.68% |
| 2001 FY | 4.27 Million USD | 1823.39% |
| 2001 Q3 | 352.97 Thousand USD | 142.28% |
| 2000 Q4 | 81.56 Thousand USD | 58.07% |
| 2000 Q2 | - USD | -100.0% |
| 2000 FY | 222.11 Thousand USD | -67.29% |
| 2000 Q1 | 68.91 Thousand USD | -83.25% |
| 2000 Q3 | 51.6 Thousand USD | 0.0% |
| 1999 Q4 | 411.46 Thousand USD | 0.0% |
| 1999 FY | 679.09 Thousand USD | 160.77% |
| 1999 Q1 | 132.58 Thousand USD | 0.0% |
| 1999 Q3 | - USD | -100.0% |
| 1999 Q2 | 135.64 Thousand USD | 2.31% |
| 1998 FY | 260.41 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Absci Corporation | -41.84 Million USD | 485.589% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -70.355% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 89.369% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 318123.256% |
| Apollomics, Inc. | 127 Thousand USD | -126959.055% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 152799.314% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 701686.957% |
| Bicycle Therapeutics plc | -129.52 Million USD | 224.587% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -20020.324% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -134370.833% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -704.733% |
| Chimerix, Inc. | 324 Thousand USD | -49704.012% |
| CRISPR Therapeutics AG | 240.95 Million USD | 33.031% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -223.994% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -289.902% |
| Fortress Biotech, Inc. | 57.85 Million USD | -178.922% |
| Fortress Biotech, Inc. | 57.85 Million USD | -178.922% |
| Gritstone bio, Inc. | -6.26 Million USD | 2677.716% |
| Allakos Inc. | -6.14 Million USD | 2727.667% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 16961.546% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -990.746% |
| Cytokinetics, Incorporated | -322.59 Million USD | 150.021% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 92308.571% |
| Innoviva, Inc. | 261.06 Million USD | 38.19% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1414589.832% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 4644.213% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 1605562.143% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 18416.118% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 40542.356% |
| ImmuCell Corporation | 4.39 Million USD | -3570.486% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 252.055% |
| Incyte Corporation | 3.44 Billion USD | 95.31% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 6140.176% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -82775.383% |
| Mustang Bio, Inc. | -2.22 Million USD | 7352.36% |
| MiMedx Group, Inc. | 266.84 Million USD | 39.528% |
| MEI Pharma, Inc. | 49.32 Million USD | -227.133% |
| MacroGenics, Inc. | 50.52 Million USD | -219.364% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Mereo BioPharma Group plc | 7.42 Million USD | -2072.973% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 2370.937% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -455.378% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -15.095% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 520934.678% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 166455.67% |
| NextCure, Inc. | -3.68 Million USD | 4480.157% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -6169.037% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -747.372% |
| Onconetix, Inc. | -1.12 Million USD | 14416.005% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 657.046% |
| Opthea Limited | 21.72 Thousand USD | -742832.781% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 13492.62% |
| Psyence Biomedical Ltd. | -240.00 USD | 67235516.667% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 281586.585% |
| Precigen, Inc. | 106 Thousand USD | -152131.132% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -15892.567% |
| Prime Medicine, Inc. | -147.9 Million USD | 209.1% |
| PureTech Health plc | -1.6 Million USD | 10166.438% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 2373.387% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 98.572% |
| Replimune Group, Inc. | -2.65 Million USD | 6177.778% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 644297.373% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -47.0% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 31327.141% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 140.375% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -303.413% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 456.018% |
| Solid Biosciences Inc. | -76.56 Million USD | 310.761% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 1344808.333% |
| SciSparc Ltd. | 2.19 Million USD | -7248.133% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 704.499% |
| TG Therapeutics, Inc. | 219.1 Million USD | 26.354% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -5230.856% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 9432.851% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -20.612% |
| UroGen Pharma Ltd. | 73.35 Million USD | -119.987% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -3585.815% |
| XOMA Corporation | 3.86 Million USD | -4079.358% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 11717.351% |
| AbCellera Biologics Inc. | 38.02 Million USD | -324.366% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 3227400.0% |
| Cassava Sciences, Inc. | -89.42 Million USD | 280.451% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 617.732% |
| Precision BioSciences, Inc. | 40.47 Million USD | -298.708% |
| Dyadic International, Inc. | 922.95 Thousand USD | -17383.48% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 109872.109% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -666.179% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -37957.783% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1957.546% |
| IGM Biosciences, Inc. | -211.66 Million USD | 176.238% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 8184.419% |
| Acelyrin, Inc. | -115 Thousand USD | 140417.391% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -6526.899% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -34.748% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1308.016% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -4.247% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 264.294% |
| Senti Biosciences, Inc. | -2.68 Million USD | 6114.35% |
| Mesoblast Limited | -9.81 Million USD | 1744.065% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 246.046% |
| ChromaDex Corporation | 50.78 Million USD | -217.773% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -33.942% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 7.02 Million USD | -2196.357% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -19.292% |
| Novavax, Inc. | 639.93 Million USD | 74.784% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 264.385% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 471.27% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -124026.923% |
| Celcuity Inc. | -142.77 Thousand USD | 113122.862% |
| ContextLogic Inc. | 59 Million USD | -173.5% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -31233.01% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -873.427% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 95.252% |
| Amarin Corporation plc | 165.54 Million USD | 2.523% |
| AnaptysBio, Inc. | 14.78 Million USD | -991.706% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 28559.436% |
| Aptorum Group Limited | -1.11 Million USD | 14576.248% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -559.953% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 32.97% |
| Ardelyx, Inc. | 106.66 Million USD | -51.288% |
| Celularity Inc. | 6.75 Million USD | -2288.823% |
| Omeros Corporation | -69.77 Million USD | 331.252% |
| Humacyte, Inc. | -76.55 Million USD | 310.797% |
| Immunocore Holdings plc | 248.39 Million USD | 35.036% |
| IO Biotech, Inc. | -756 Thousand USD | 21444.577% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 11415.919% |
| Summit Therapeutics Inc. | -2.05 Million USD | 7971.463% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 3463.172% |
| Pulmatrix, Inc. | -8.22 Million USD | 2063.078% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 140.463% |
| Evogene Ltd. | 1.39 Million USD | -11434.31% |
| CorMedix Inc. | -205.56 Thousand USD | 78599.431% |
| BioLineRx Ltd. | 1.1 Million USD | -14463.628% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -32433.266% |
| Sagimet Biosciences Inc. | 2 Million USD | -7968.25% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 81.502% |
| scPharmaceuticals Inc. | 9.78 Million USD | -1549.612% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 333.876% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 66.092% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1414589.832% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 556531.034% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 85478.307% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -3883.337% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 30836.19% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 365278.329% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1644.908% |
| Daré Bioscience, Inc. | 2.76 Million USD | -5726.457% |
| bluebird bio, Inc. | -4.03 Million USD | 4104.094% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 91.527% |
| DBV Technologies S.A. | 15.72 Million USD | -925.973% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 188.951% |
| Galecto, Inc. | -830 Thousand USD | 19541.566% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 28360.07% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 510.149% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -26396.716% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 112705.634% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -195.437% |
| ADMA Biologics, Inc. | 88.21 Million USD | -82.916% |
| Clene Inc. | 533 Thousand USD | -30174.859% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -8016.952% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 34104.151% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 1551686.538% |
| Soligenix, Inc. | 97.31 Thousand USD | -165724.008% |
| Century Therapeutics, Inc. | -10.8 Million USD | 1592.876% |
| Kura Oncology, Inc. | -849 Thousand USD | 19106.478% |
| Surrozen, Inc. | -27.23 Million USD | 692.6% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 340.47% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -62.931% |
| Autolus Therapeutics plc | -4.86 Million USD | 3415.492% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 96150.595% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 307.95% |
| GRI Bio, Inc. | 10.84 Million USD | -1388.47% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -6252.988% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 444.51% |
| INmune Bio, Inc. | 155 Thousand USD | -104006.452% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -160.522% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 10812.737% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 24984.572% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 2131738.045% |
| Jaguar Health, Inc. | 7.72 Million USD | -1989.138% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 551322.928% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -40040.547% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -1950.121% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 51654.313% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -70.827% |
| Verastem, Inc. | -62 Thousand USD | 260366.129% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 61925.67% |
| Histogen Inc. | 3.76 Million USD | -4181.374% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -27906.054% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 76.294% |
| Surrozen, Inc. | -27.23 Million USD | 692.6% |
| Organovo Holdings, Inc. | -5.38 Million USD | 3094.34% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 8149847.475% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -2559.969% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 240473.3% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -110575.583% |
| Kronos Bio, Inc. | 1.37 Million USD | -11661.297% |
| Turnstone Biologics Corp. | 16.5 Million USD | -877.614% |
| Synaptogenix, Inc. | -6347.00 USD | 2542482.228% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 316501.961% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -453.967% |
| Exelixis, Inc. | 1.75 Billion USD | 90.819% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 243.869% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 52.27% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 14663.628% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 136283.339% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -2105.042% |
| Insmed Incorporated | 239.63 Million USD | 32.662% |
| MediWound Ltd. | 3.57 Million USD | -4409.922% |
| OmniAb, Inc. | 14.66 Million USD | -1000.191% |
| Alector, Inc. | -95.05 Million USD | 269.763% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -28.454% |
| Zai Lab Limited | 170.9 Million USD | 5.581% |
| AlloVir, Inc. | -398 Thousand USD | 40643.97% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -97.082% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 15736.143% |
| Aura Biosciences, Inc. | -1.29 Million USD | 12560.618% |
| Immunic, Inc. | -111 Thousand USD | 145473.874% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -917.819% |
| Veracyte, Inc. | 248.14 Million USD | 34.972% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 102.309% |
| FibroGen, Inc. | 128.9 Million USD | -25.182% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 48.556% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 28610915.603% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1483.103% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -41382.005% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 54.589% |
| Fortrea Holdings Inc. | 424 Million USD | 61.942% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 287.27% |
| XBiotech Inc. | -1.74 Million USD | 9352.58% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 14663.628% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 24401.958% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 447.238% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 313.632% |
| Agenus Inc. | 139.61 Million USD | -15.579% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -119.834% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -860.334% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 58.522% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 425.025% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 50.615% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 1525.002% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 266.441% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -2988140.741% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 241566.772% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 92391.37% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 43245.722% |
| Ainos, Inc. | -253.73 Thousand USD | 63696.379% |
| Pluri Inc. | 322 Thousand USD | -50013.354% |
| Prothena Corporation plc | -129.2 Million USD | 224.895% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -220.017% |
| Rallybio Corporation | -150 Thousand USD | 107676.667% |
| Kodiak Sciences Inc. | -25.94 Million USD | 721.902% |
| Cue Biopharma, Inc. | -32.6 Million USD | 594.878% |
| MeiraGTx Holdings plc | 287 Thousand USD | -56124.739% |
| Annexon, Inc. | -3.26 Million USD | 5039.241% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 486.623% |
| Moderna, Inc. | 2.15 Billion USD | 92.512% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1163.781% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -158.672% |
| Blueprint Medicines Corporation | 236.58 Million USD | 31.794% |
| Immix Biopharma, Inc. | -5468.00 USD | 2951179.005% |
| CalciMedica, Inc. | -58 Thousand USD | 278315.517% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 2693.459% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 5773.875% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -55.011% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 622.809% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 13891.88% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -5713.729% |
| Nutriband Inc. | 862.1 Thousand USD | -18617.558% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 47421.114% |
| Vor Biopharma Inc. | -3.49 Million USD | 4720.991% |
| Roivant Sciences Ltd. | 109.23 Million USD | -47.723% |
| Alkermes plc | 1.37 Billion USD | 88.262% |
| ProKidney Corp. | -3.16 Million USD | 5191.985% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 467.474% |
| Arcellx, Inc. | 108.27 Million USD | -49.027% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -2253.289% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 305.114% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 489084.848% |
| Atai Life Sciences N.V. | -5000.00 USD | 3227400.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 132519.436% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 168188.542% |
| MediciNova, Inc. | 979.7 Thousand USD | -16370.774% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 291.374% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 170757.289% |
| GeoVax Labs, Inc. | -20.72 Million USD | 878.76% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 34.011% |
| Biomea Fusion, Inc. | -4.2 Million USD | 3941.109% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 52153.226% |
| Geron Corporation | -123.5 Million USD | 230.657% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 3227400.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 311.285% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 6656.887% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 24.502% |
| Royalty Pharma plc | 1.79 Billion USD | 91.005% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 17248.247% |
| Imunon, Inc. | -720 Thousand USD | 22511.65% |
| BioAtla, Inc. | -103.73 Million USD | 255.561% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 166.455% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 51985.852% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 244.834% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 17100.571% |
| 89bio, Inc. | -273 Thousand USD | 59208.059% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 330.242% |
| aTyr Pharma, Inc. | -2.38 Million USD | 6857.328% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -1195.064% |
| Viridian Therapeutics, Inc. | -1 Million USD | 16108.433% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1241269130.769% |
| Akari Therapeutics, Plc | -4000.00 USD | 4034225.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 74.664% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -14320.465% |
| Liquidia Corporation | 14.6 Million USD | -1005.24% |
| Entera Bio Ltd. | -56 Thousand USD | 288251.786% |
| GH Research PLC | -315 Thousand USD | 51326.984% |
| Vericel Corporation | 135.57 Million USD | -19.022% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 390.439% |
| Xencor, Inc. | -85.26 Million USD | 289.262% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 73123.437% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 24984.572% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 16216.58% |
| Vaxcyte, Inc. | -75 Million USD | 315.153% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 196.33% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 9.266% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -82775.383% |
| Portage Biotech Inc. | -54 Thousand USD | 298924.074% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 170757.289% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 42902.387% |
| OncoCyte Corporation | 413 Thousand USD | -38971.429% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 3589977.642% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 72687036.937% |
| Purple Biotech Ltd. | -196 Thousand USD | 82429.082% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 42453.018% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 833.911% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -136.863% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -1699.342% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 127159.055% |
| United Therapeutics Corporation | 2.07 Billion USD | 92.205% |
| HilleVax, Inc. | -2.15 Million USD | 7584.462% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -243418.351% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 4193.431% |
| Pharming Group N.V. | 220.1 Million USD | 26.687% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 1075579.872% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 24256.437% |
| Pyxis Oncology, Inc. | -2 Million USD | 8168.25% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 2149867.657% |
| Savara Inc. | -44.26 Million USD | 464.568% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 196886.585% |
| Curis, Inc. | 9.81 Million USD | -1544.736% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 129411.312% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 70874.123% |
| BeiGene, Ltd. | 2.07 Billion USD | 92.238% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -184.655% |
| Erasca, Inc. | -3.73 Million USD | 4423.821% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 571951.301% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 571951.301% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 17735.519% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1915.551% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 30205.41% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 245.206% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 4597.352% |
| Adicet Bio, Inc. | -6.09 Million USD | 2746.195% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 55.428% |
| Aditxt, Inc. | -111.66 Thousand USD | 144614.598% |
| Adagene Inc. | 18.11 Million USD | -790.954% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -32966.598% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -2.236% |
| Compugen Ltd. | 31.45 Million USD | -413.003% |
| Generation Bio Co. | -73.91 Million USD | 318.323% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 37025.629% |
| Invivyd, Inc. | -2.02 Million USD | 8056.854% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 153.638% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 156101.663% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -67.447% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -64.176% |
| Instil Bio, Inc. | -4.75 Million USD | 3492.872% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -569.309% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -14122.444% |
| GeoVax Labs, Inc. | -20.72 Million USD | 878.76% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 83142.57% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 19402.033% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -93.448% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -220609.323% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -203.534% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 193.173% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 45812.465% |
| Cingulate Inc. | -582.91 Thousand USD | 27782.281% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 520632.258% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 919.153% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 16432.49% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 286502.684% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 400.684% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 55361.986% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 30719.545% |
| ImmunityBio, Inc. | -17.89 Million USD | 1001.984% |
| Korro Bio, Inc. | -3.63 Million USD | 4545.317% |
| Kineta, Inc. | 5.43 Million USD | -2870.09% |
| BioVie Inc. | -229.37 Thousand USD | 70449.25% |
| Codexis, Inc. | 57.33 Million USD | -181.447% |
| Celularity Inc. | 6.75 Million USD | -2288.823% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 135700.84% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -3921.057% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -318866.199% |
| Cibus, Inc. | 1.42 Million USD | -11247.75% |
| IN8bio, Inc. | -2.5 Million USD | 6552.019% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 7994.569% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -25113.281% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 79.273% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 6.701% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | -39 Thousand USD | 413856.41% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 8592.895% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 598.517% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -103.733% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 862.883% |
| Moolec Science SA | -143.3 Thousand USD | 112702.491% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 481.315% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -4809.188% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 330.225% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 8637.831% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 4467569.546% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -69636.939% |
| Humacyte, Inc. | -76.55 Million USD | 310.797% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 12937.311% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 19128.892% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 131291.057% |
| Notable Labs, Ltd. | 113 Thousand USD | -142700.885% |
| Immunovant, Inc. | -231 Thousand USD | 69954.978% |
| Quantum-Si incorporated | 488 Thousand USD | -32966.598% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 537983.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -8566.219% |
| Acasti Pharma Inc. | -11 Thousand USD | 1467054.545% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 78961.971% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 8341.318% |
| PepGen Inc. | -1.18 Million USD | 13728.801% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 804.743% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 195497.358% |
| Immuneering Corporation | -764.13 Thousand USD | 21217.259% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | -399 Thousand USD | 40542.356% |
| XOMA Corporation | 3.86 Million USD | -4079.358% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 905.375% |
| Bionomics Limited | -434.44 Thousand USD | 37242.449% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 15124.674% |
| uniQure N.V. | 2.21 Million USD | -7185.102% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 275.265% |
| Forte Biosciences, Inc. | -9000.00 USD | 1793044.444% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 19425.15% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 37025.629% |
| Altimmune, Inc. | -65.37 Million USD | 346.837% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 6803.988% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 15124.674% |
| Peak Bio, Inc. | 367.76 Thousand USD | -43776.727% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -558.203% |
| Benitec Biopharma Inc. | 108 Thousand USD | -149312.037% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 206978.205% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 13513.549% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 8956.476% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 13513.549% |
| argenx SE | 1.1 Billion USD | 85.443% |
| Immunome, Inc. | -8.9 Million USD | 1911.665% |
| Verona Pharma plc | -679.62 Thousand USD | 23843.276% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 92308.571% |
| Shattuck Labs, Inc. | -2.38 Million USD | 6865.828% |
| CervoMed Inc. | -1.29 Million USD | 12573.843% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 3477.957% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -6430.352% |
| Moolec Science SA | -143.3 Thousand USD | 112702.491% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 39647.337% |
| Design Therapeutics, Inc. | -537 Thousand USD | 30149.348% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 37890.398% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -7419.338% |
| Achilles Therapeutics plc | -4.73 Million USD | 3510.609% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 454.275% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -375167.442% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 19730.779% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1226464.189% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 489084.848% |
| Beam Therapeutics Inc. | -59.67 Million USD | 370.42% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -15.811% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -648.967% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 54431.65% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 4107.04% |
| NeurAxis, Inc. | 2.15 Million USD | -7382.019% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1786.86% |
| Lumos Pharma, Inc. | 2 Million USD | -7940.11% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -409.701% |
| Palisade Bio, Inc. | 246 Thousand USD | -65495.528% |
| Nutriband Inc. | 862.1 Thousand USD | -18617.558% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -1046.058% |
| Neurogene Inc. | -3.26 Million USD | 5046.812% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 293490.909% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 4470.666% |
| Athira Pharma, Inc. | -969 Thousand USD | 16752.735% |
| HCW Biologics Inc. | -574.82 Thousand USD | 28172.071% |
| XOMA Corporation | 3.86 Million USD | -4079.358% |
| Nektar Therapeutics | 53.47 Million USD | -201.741% |
| Arvinas, Inc. | 71.8 Million USD | -124.742% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 293.342% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 357.053% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 50213.354% |
| Rezolute, Inc. | -36 Thousand USD | 448336.111% |
| Clene Inc. | 533 Thousand USD | -30174.859% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 12567467.601% |
| BeyondSpring Inc. | 1.75 Million USD | -9115.591% |
| Synlogic, Inc. | -1.92 Million USD | 8486.954% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 436221.622% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 2648.405% |
| Peak Bio, Inc. | 367.76 Thousand USD | -43776.727% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 950.947% |
| Krystal Biotech, Inc. | 47.6 Million USD | -238.966% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -14.369% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -3111.244% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 6332.188% |
| MannKind Corporation | 136.19 Million USD | -18.484% |
| Ikena Oncology, Inc. | -50.49 Million USD | 419.585% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -48.294% |
| Gossamer Bio, Inc. | -4.38 Million USD | 3779.932% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 64133.73% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 3227400.0% |
| Legend Biotech Corporation | 140.92 Million USD | -14.501% |
| Mural Oncology plc | -2.56 Million USD | 6386.132% |
| Disc Medicine, Inc. | -100 Thousand USD | 161465.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -677.513% |
| REGENXBIO Inc. | 53.02 Million USD | -204.296% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 3112.253% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 83980.442% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 9416.686% |
| Vaxart, Inc. | -60.76 Million USD | 365.565% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 61506.88% |
| Cellectis S.A. | 18 Thousand USD | -896372.222% |
| Longeveron Inc. | 221 Thousand USD | -72915.837% |
| Repare Therapeutics Inc. | -80.07 Million USD | 301.53% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 85.236% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 12570.247% |
| Revolution Medicines, Inc. | -399.66 Million USD | 140.375% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 461142.857% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -329216.327% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.125% |
| Denali Therapeutics Inc. | -93.34 Million USD | 272.869% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 644297.373% |
| Veru Inc. | 7.56 Million USD | -2032.785% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 106964.238% |
| Cingulate Inc. | -582.91 Thousand USD | 27782.281% |
| Passage Bio, Inc. | -3.72 Million USD | 4436.603% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 1339895.749% |
| Exicure, Inc. | -1.42 Million USD | 11439.775% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 42231.854% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -5869.848% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 31575.106% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 107959.258% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 372.548% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -41169.821% |
| OmniAb, Inc. | 14.66 Million USD | -1000.191% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -707.107% |
| Lipocine Inc. | -2.85 Million USD | 5760.305% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 8855.562% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 2928.484% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 10812.737% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -114.251% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 248353.846% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -91.427% |
| Ocugen, Inc. | -33.53 Million USD | 581.155% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 5203.257% |
| Q32 Bio Inc. | 578 Thousand USD | -27817.82% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 60992.453% |
| Alumis Inc. Common Stock | -1.28 Million USD | 12667.368% |
| Equillium, Inc. | 35.95 Million USD | -348.76% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 9553.134% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -32129.233% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 3903462.361% |
| Dominari Holdings Inc. | 2.03 Million USD | -7813.928% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 88051.229% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1286.944% |
| Bio-Techne Corporation | 773.07 Million USD | 79.127% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -831.722% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 64.98% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 13903.678% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 772.915% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -1279.542% |
| Nkarta, Inc. | -5.86 Million USD | 2849.446% |
| BioCardia, Inc. | -7.24 Million USD | 2326.031% |
| Iterum Therapeutics plc | -1.75 Million USD | 9320.857% |